News-Medical.netAggressive cancer stem cells can now be isolated successfully in a scientific breakthroughNews-Medical.netStem cells and cancer recurrence and spread are innately connected. Stem cells are mother cells that can turn into any cells of th… Continue reading
Mobile Computing Today |
CAR T Cell Therapy Products And Increasing Number Of Patients Suffering With Refractory B Cell Acute Lymphocytic …
Mobile Computing Today Recent approval of CD19 antigens as CAR T cell therapy for the treatment of b cell acute lymphocytic leukemia and increasing number of children suffering with acute lymphocytic leukemia is responsible for the dominance of ALL. Non-Hodgkin’s lymphoma … |
Mobile Computing Today |
CAR T Cell Therapy Products And Increasing Number Of Patients Suffering With Refractory B Cell Acute Lymphocytic …
Mobile Computing Today Recent approval of CD19 antigens as CAR T cell therapy for the treatment of b cell acute lymphocytic leukemia and increasing number of children suffering with acute lymphocytic leukemia is responsible for the dominance of ALL. Non-Hodgkin’s lymphoma … |
Yahoo7 News |
Mesoblast stem cell therapy meets goal of pediatric Graft vs. Host study
Reuters In patients who receive an allogeneic (from a healthy donor) bone marrow transplant for conditions such as blood cancers, donor cells may attack the recipient causing aGVHD, which activates an inflammatory response by the immune system and potential … Primary Endpoint Successfully Achieved in Mesoblast’s Phase 3 Cell Therapy Trial for Acute Graft Versus Host DiseaseGlobeNewswire (press release) |
OncLive |
Dr. Wise Discusses Challenges With Immunotherapy in Prostate Cancer
OncLive David R. Wise, MD, PhD, assistant professor, Department of Medicine, assistant professor, Department of Urology, NYU Langone’s Perlmutter Cancer Center, discusses challenges with immunotherapy in prostate cancer. The community has hit a significant … |